Alternatives to Augmanity Nano

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

AI platform for accelerating novel peptide therapeutic discovery and development.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

BiotaX leverages an AI-powered microbial ecology platform to discover and engineer natural microbial communities for health, food, and climate applications.

AI-powered platform for designing novel molecular structures for new medicines.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Develops a computational model of the human body for drug discovery and development.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

AI-driven drug discovery platform accelerating breakthrough scientific research.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.